TrialAnnals of surgical oncology2021

Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases.

Rajesh Ramanathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.